La vendita allo scoperto per Macerich dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Macerich. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Macerich (NYSE:MAC) Azioni, Report sulle vendite allo scoperto

Macerich

The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.

Macerich Co

MORINGA ACQUISITION CORP USD CL A ORD SHS

MORINGA ACQUISITION CORP USD UNITS CONSISTING ONE CL A ORD SH & ONE HALF WT TO PUR CL

MORINGA ACQUISITION CORP USD WTS TO PUR CL A ORD SHS

MACE SECURITY INTL INC by Mace Security International, Inc.

Mace Security International Inc

Melar Acquisition Corp. I - Class A Ordinary Shares

Melar Acquisition Corp I

Merrimack Pharmaceuticals Inc Com (New)

THEMAC RESOURCES GRP LTD by Themac Resources Group Ltd.

Themac Resources Group Ltd

MODIV ACQUISITION CORP.

Machten Inc

ISH CONS PORT ETF

As of Sept. 30, 2024, four stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">KE Holdings Inc &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)</h3>
<ul>
<li>On Aug. 12, KE Holdings reported better-than-expected second-quarter financial results and increased its repurchase authorization. The company's stock gained around 37% over the past five days and has a <a href="https://www.benzinga.com/quote/BEKE">52-week high of $20.48</a>.</li>
<li>RSI Value: 81.63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BEKE Price Action: Shares of KE Holdings gained 1.6% to close at $20.00 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Uniti Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>)</h3>
<ul>
<li>On Sept. 27, Uniti Group announced $800 million windstream notes as part of post-merger debt restructuring. The company's stock gained around 34% over the past month and <a href="https://www.benzinga.com/quote/UNIT">has a 52-week high</a> of $6.71.</li>
<li>RSI Value: 78.03</li>
<li>UNIT Price Action: Shares of Uniti Group rose 7.6% to close at $5.84 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Macerich Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>)</h3>
<ul>
<li>On Sept. 19, Goldman Sachs analyst Caitlin Burrows maintained Macerich with a Sell and raised the price target from $13 to $14.6. The company's stock gained around 18% over the past month and has a <a href="https://www.benzinga.com/quote/MAC">52-week high </a>of $18.04.</li>
<li>RSI Value: 77.29</li>
<li>MAC Price Action: Shares of Macerich gained 3.3% to close at $17.95 on Friday.</li>
</ul>
<h3 class="wp-block-heading">American Healthcare REIT Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>)</h3>
<ul>
<li>On Sept. 24, American Healthcare REIT acquired remaining 24% membership interest in Trilogy REIT Holdings for purchase price of $258 million. The company's stock jumped around 24% over the past month and has a 52-week high is $26.77.</li>
<li>RSI Value: 80.83</li>
<li>AHR Price Action: Shares of American Healthcare fell 0.2% to close at $26.12 on Friday. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/41075978/top-4-materials-stocks-that-may-implode-in-q3">Top 4 Materials Stocks That May Implode In Q3</a></li>
</ul>

BEKE

UNIT

Top 4 Real Estate Stocks You May Want To Dump In September

Goldman Sachs analyst Caitlin Burrows maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Sell and raises the price target from $13 to $14.6.

News

Price Target

Analyst Ratings

Goldman Sachs Maintains Sell on Macerich, Raises Price Target to $14.6

Piper Sandler analyst Alexander Goldfarb maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Underweight and raises the price target from $11 to $14.

Piper Sandler Maintains Underweight on Macerich, Raises Price Target to $14

Evercore ISI Group analyst Samir Khanal maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a In-Line and raises the price target from $15 to $16.

Evercore ISI Group Maintains In-Line on Macerich, Raises Price Target to $16

Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.40 by 2.5 percent. This is a 2.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $215.521 million which beat the analyst consensus estimate of $205.006 million by 5.13 percent. This is a 1.48 percent increase over sales of $212.374 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Macerich Q2 2024 FFO Per Share Excluding Financing Expense $0.39 Misses $0.40 Estimate, Sales $215.521M Beat $205.006M Estimate

Goldman Sachs analyst Caitlin Burrows maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Sell and lowers the price target from $14 to $12.5.

Goldman Sachs Maintains Sell on Macerich, Lowers Price Target to $12.5

WIIM

LAMR

Shares of REIT stocks are trading higher amid a drop in Treasury yields following soft May CPI figures.

Macerich&#39;s plan is designed to:
<ul>
<li>Deleverage the capital structure to a&nbsp;low-to-mid 6x range&nbsp;over the next three to four years.</li>
<li>Invest in and fortify key assets in the portfolio.</li>
<li>Proactively consolidate selected joint venture assets that are core to the overall strategy.</li>
<li>Deliver clean FFO/share launch point of&nbsp;~$1.80/share&nbsp;over the next three to four years.</li>
<li>Improve various internal processes that are being evaluated and realigned to achieve outstanding operational results.</li>
<li>Position the company to take an offensive stance on acquisitions, reinvestment, and selected development.</li>
</ul>

Macerich Unveils Path-Forward Plan; To Invest In And Fortify Key Assets In Portfolio

Scotiabank analyst Greg McGinniss downgrades Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) from Sector Perform to Sector Underperform and lowers the price target from $16 to $14.

Downgrades

Scotiabank Downgrades Macerich to Sector Underperform, Lowers Price Target to $14

This transaction, which closed on May 14, gives Macerich full ownership of both properties.&nbsp;Additionally, Macerich has executed a contract for the sale of an open-air asset in a major market. The transaction is expected to generate approximately&nbsp;$110,000&nbsp;million of net proceeds based on an expected cap rate of&nbsp;6.5%&nbsp;and is anticipated to close this summer.

Macerich Purchases Remaining 40% Share Of Both Arrowhead Towne Center (Metro Phoenix) And South Plains Mall (Lubbock, Texas) For $36.5M Plus Debt

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Macerich Company</h3>
<ul>
<li>The Trade: The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) CFO Scott W Kingsmore <a href="https://www.benzinga.com/quote/AON/analyst-ratings">acquired a total of 6,000 shares</a> an average price of $16.06. To acquire these shares, it cost around $96,360.</li>
<li>What's Happening: On April 30, Macerich posted better-than-expected first-quarter sales.</li>
<li>What Macerich Does: The Macerich Company is an S&amp;P 500 company that invests in premium mall assets.</li>
</ul>
<h3 class="wp-block-heading">XPEL</h3>
<ul>
<li>The Trade: XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) Director John F North acquired a total of 3,000 shares at an average price of $32.17. To acquire these shares, it cost around $96,510.</li>
<li>What's Happening: On May 2, XPEL posted worse-than-expected first-quarter results.</li>
<li>What XPEL Does: XPEL Inc is a provider of protective films and coatings, including automotive paint protection film, surface protection film, automotive and commercial/residential window films, and ceramic coatings.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
PPG Industries
<ul>
<li>The Trade: PPG Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) Chairman and CEO Timothy M Knavish <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 2,061 shares</a> at an average price of $133.24. To acquire these shares, it cost around $274,615.</li>
<li>What's Happening: On April 18, PPG Industries reported mixed first-quarter financial results.</li>
<li>What PPG Industries Does: PPG is a global producer of coatings.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/24/05/38753455/enbridge-funko-and-3-stocks-to-watch-heading-into-friday">Enbridge, Funko And 3 Stocks To Watch Heading Into Friday</a>

Long Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

XPEL

Insiders Buying PPG Industries And 2 Other Stocks

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Herbalife</h3>
<ul>
<li>The Trade: Herbalife Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) Director Donal L Mulligan <a href="https://www.benzinga.com/quote/HTLD/analyst-ratings">acquired a total of 45,657 shares</a> at an average price of $9.65. To acquire these shares, it cost around $289,500.</li>
<li>What's Happening: On May 1, Herbalife Nutrition reported better-than-expected first-quarter adjusted EPS.</li>
<li>What Herbalife Does: Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model.</li>
</ul>
<h3 class="wp-block-heading">Macerich</h3>
<ul>
<li>The Trade: The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) President and CEO Jackson Hsieh acquired a total of 140,000 shares at an average price of $14.26. To acquire these shares, it cost around $2 million.</li>
<li>What's Happening: On April 30, Macerich posted better-than-expected first-quarter sales.</li>
<li>What Macerich Does: The Macerich Company is an S&amp;P 500 company that invests in premium mall assets.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a> 
<h3 class="wp-block-heading">AMREP</h3>
<ul>
<li>The Trade: AMREP Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXR#NYSE">AXR</a>) 10% owner Rainey E. Lancaster <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 10,000 shares</a> at an average price of $20.95. To acquire these shares, it cost around $209,500.</li>
<li>What's Happening: On March 8, AMREP reported earnings of 2 cents per share for its 2024 fiscal third quarter, versus year-ago earnings of $3.12 per share.</li>
<li>What AMREP Does: Amrep Corp through its subsidiaries is engaged in the Real estate business.</li>
</ul>
<h3 class="wp-block-heading">Sensata Technologies</h3>
<ul>
<li>The Trade: Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) Director Ali John Mirshekari <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 268,310 shares</a> at an average price of $39.64. The insider spent around $10.64 million to buy those shares.</li>
<li>What's Happening: On April 29, Sensata Technologies reported better-than-expected first-quarter financial results.</li>
<li>What Sensata Technologies Does: Sensata Technologies is a global supplier of sensors for transportation and industrial applications.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/05/38661451/disney-electronic-arts-and-3-stocks-to-watch-heading-into-tuesday">Disney, Electronic Arts And 3 Stocks To Watch Heading Into Tuesday</a>

Over $10M Bet On Sensata Technologies? Check Out These 4 Stocks Insiders Are Buying

Macerich Form 4 Filing Shows Director, President And CEO Jackson Hsieh Bought 140,000 Shares Of Stock At A Price Of $14.26/Share

The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) shares traded lower on Wednesday after Piper Sandler analyst Alexander Goldfarb downgraded the stock from Neutral to Under Weight and lowered the price target <a href="https://www.benzinga.com/quote/MAC/analyst-ratings">from $17 to $11.</a>
On Tuesday, the company reported Q1 sales&nbsp;of $208.783 million, beating the consensus of<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38515692/macerich-reports-first-quarter-2024-results" rel="noreferrer noopener">&nbsp;$205.112 million and FFO of&nbsp;$0.33</a>.
The company welcomed Jackson Hsieh as the new CEO and president <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">and withdrew its FY24 guidance</a>.
The analyst writes that they think Hsieh is asking shareholders for another 3–4 years to restructure the company after enduring the same game plan that was executed twice before over the past decade is &#8220;a bridge too far.&#8221;
Goldfarb argues that management is opting not to directly tackle the balance sheet issues. Instead, they plan to pursue growth in Net Operating Income (NOI) through strategies such as leasing, asset givebacks, and a planned injection of just $500 million in equity over the next three to four years.
Consequently, the analyst lowered estimates for FY24 FFO by $0.23 to $1.58 and FY25 by $0.32 to $1.50, which reflects Q1 results, expected $15 million annualized impact of 15 Express store closures, refinancings, and assumption of H2 FY24 dispositions of $400 million and $600 million in FY25. 
Investors can gain exposure to the stock via&nbsp;Invesco S&amp;P SmallCap Financials ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSCF#NASDAQ">PSCF</a>) and&nbsp;Vanguard S&amp;P Small-Cap 600 Value ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIOV#NYSE">VIOV</a>).
Price Action: MAC shares closed down 2.18% at $13.46 on Wednesday.
Now Read: <a href="https://www.benzinga.com/markets/equities/24/05/38563545/powell-keeps-hawks-at-bay-says-interest-rate-hike-unlikely-stocks-gold-rally-while-treasury-yiel">Powell Keeps Hawks At Bay, Says Interest Rate Hike &#8216;Unlikely&#8217;: Stocks, Gold Rally, While Treasury Yields, Dollar Tumble</a>
Photo: Shutterstock

Equities

Large Cap

PSCF

VIOV

Analyst Doubts Macerich's New CEO Strategy, Can They Turn Things Around?

Ratings for Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Macerich, presenting an average target of $15.2, a high estimate of $18.00, and a low estimate of $11.00. A decline of 1.94% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1714590080_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Macerich by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Floris Van Dijkum</td>
<td>Compass Point</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$14.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Alexander Goldfarb</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$11.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Hold</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Nicholas Joseph</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Macerich. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Macerich compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Macerich's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Macerich's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MAC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Macerich analyst ratings.</a>
<h2>Unveiling the Story Behind Macerich</h2>
The Macerich Company is an S&amp;P 500 company that invests in premium mall assets. The company owns 27 regional malls in its consolidated portfolio and 16 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 46.3 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.
<h3>Macerich: A Financial Overview</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Macerich's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.58% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Macerich's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 25.96%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Macerich's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.54%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.82%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Macerich's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.76.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For Macerich

Compass Point analyst Floris Van Dijkum maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Buy and lowers the price target from $20 to $18.

Compass Point Maintains Buy on Macerich, Lowers Price Target to $18

Mizuho analyst Haendel St. Juste maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Underperform and lowers the price target from $17 to $14.

Mizuho Maintains Underperform on Macerich, Lowers Price Target to $14

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Baird cut the price target for Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) from $536 to $517. Baird analyst Jeffrey Meuler maintained an Outperform rating. Gartner shares fell 8% to close at $412.59 on Tuesday. <a href="https://www.benzinga.com/quote/IT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho boosted the price target for Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) from $230 to $240. Mizuho analyst James Lee maintained a Buy rating. Amazon shares fell 3.3% to close at $175.00 on Tuesday. <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG slashed Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) price target from $115 to $100. BTIG analyst Peter Saleh maintained a Buy rating. Starbucks shares rose 0.2% to close at $88.49 on Tuesday. <a href="https://www.benzinga.com/quote/SBUX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JMP Securities raised the price target for PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) from $70 to $82. JMP Securities analyst David Scharf maintained a Market Outperform rating. PayPal shares rose 1.4% to close at $67.92 on Tuesday. <a href="https://www.benzinga.com/quote/PYPL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen raised Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) price target from $300 to $375. TD Cowen analyst Joseph Giordano maintained a Buy rating. Zebra Technologies shares rose 4.9% to close at $314.56 on Tuesday. <a href="https://www.benzinga.com/quote/ZBRA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital slashed McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) price target from $335 to $330. BMO Capital analyst Andrew Strelzik maintained an Outperform rating. McDonald&#8217;s shares fell 0.2% to close at $273.04 on Tuesday. <a href="https://www.benzinga.com/quote/MCD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham raised the price target for CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) from $23 to $26. Needham analyst James Ricchiuti maintained a Buy rating. CECO Environmental shares fell 14.9% to close at $21.62 on Tuesday. <a href="https://www.benzinga.com/quote/CECO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen cut Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) price target from $125 to $90. TD Cowen analyst Matthew Ramsay downgraded the stock from Buy to Hold. Skyworks Solutions shares fell 1.2% to close at $106.59 on Tuesday. <a href="https://www.benzinga.com/quote/SWKS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs cut Sirius XM Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) price target from $3.5 to $3.25. Goldman Sachs analyst Stephen Laszczyk upgraded the stock from Sell to Neutral. Sirius XM shares fell 7.3% to close at $2.94 on Tuesday. <a href="https://www.benzinga.com/quote/SIRI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler slashed The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) price target from $17 to $11. Piper Sandler analyst Alexander Goldfarb downgraded the stock from Neutral to Underweight. Macerich shares fell 14.1% to close at $13.76 on Tuesday. <a href="https://www.benzinga.com/quote/MAC/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/05/38546448/this-analyst-with-86-accuracy-rate-sees-more-than-24-upside-in-lattice-semiconductor-here-are-5-stoc">This Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor &#8211; Here Are 5 Stock Picks For April From Wall Street&#8217;s Most Accurate Analysts</a>

AMZN

CECO

PYPL

SBUX

SIRI

SWKS

ZBRA

Amazon To Rally Over 37%? Here Are 10 Top Analyst Forecasts For Wednesday

Piper Sandler analyst Alexander Goldfarb downgrades Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) from Neutral to Underweight and lowers the price target from $17 to $11.

Piper Sandler Downgrades Macerich to Underweight, Lowers Price Target to $11

Shares of H&amp;E Equipment Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) fell sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/HES/earnings">mixed first-quarter results</a>.
H&amp;E Equipment posted GAAP earnings of 71 cents per share, versus market estimates of 77 cents per share. The company's quarterly sales came in at $371.357 million versus expectations of $352.518 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
H&amp;E Equipment Services shares dipped 18.2% to $48.45 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares jumped 67.2% to $0.3927 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) gained 57.5% to $3.70 after the company highlighted plans for its previously-announced merger with Triller.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) climbed 55.4% to $2.12 after falling over 9% on Monday.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares gained 50.2% to $1.40 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) rose 40.8% to $15.49 after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) gained 39.4% to $7.00.</li>
<li>Swvl Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWVL#NASDAQ">SWVL</a>) surged 29.8% to $13.14 after announcing results for the fiscal year 2023.</li>
<li>Next.e.GO N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGOX#NASDAQ">EGOX</a>) gained 26.4% to $0.0349.</li>
<li>Blend Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares climbed 25.8% to $2.83 after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.</li>
<li>Daré Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) rose 24.2% to $0.3460 after the XOMA acquired an economic interest in the company&#8217;s women&#8217;s health assets. Also, the company announced that the transaction allows it to focus on advancing Phase 3 first-in-category women&#8217;s health product candidates.</li>
<li>LendingTree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) gained 24.2% to $46.39 after the company beat first-quarter estimates and issued strong guidance.</li>
<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) rose 24% to $5.85 following quarterly results.</li>
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) gained 19.8% to $6.85.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) rose 19.2% to $11.19 following a first-quarter revenue beat.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) rose 18.8% to $3.1002 after the company announced the launch of its AI-powered Anomaly Detector.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) gained 15.5% to $59.94 following upbeat quarterly results.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) gained 15.2% to $46.88 following better-than-expected earnings.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose 13.4% to $9.32 following strong quarterly earnings.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 13.3% to $1.53.</li>
<li>E2open Parent Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) rose 12.5% to $4.7950 following upbeat results.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) shares climbed 12.1% to $40.04 as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) jumped 10.3% to $8.31. Addex shares dipped 53% on Monday after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.</li>
<li>AgEagle Aerial Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#NASDAQ">UAVS</a>) gained 10.4% to $0.77. AgEagle announced $3.4 million drone sale to French Army.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) rose 9.2% to $108.28 after the company reported better-than-expected first quarter earnings and issued strong guidance.</li>
<li>Brinker International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) gained 7.5% to $53.38 after the company reported strong third-quarter financial results and raised FY24 guidance.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 6.6% to $785.51 after the company raised its FY24 revenue guidance.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) gained 5.5% to $97.25 following a first-quarter earnings beat.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 30.6% to $1.4127 after surging 48% on Monday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) declined 29.7% to $1.25.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares fell 26.1% to $5.30 after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) dipped 25% to $2.6592 after the company announced findings from its Phase 2b/3 trial of NRX-101 vs. Lurasidone.</li>
<li>Bakkt Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) fell 23.5% to $7.62. Bakkt Holdings is expected to release its first quarter 2024 earnings on Tuesday, May 14.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) shares declined 22.6% to $27.50 after the company reported mixed first-quarter financial results.</li>
<li>Vince Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) were down 21.4% to $1.6536 after the company posted fourth-quarter results.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) fell 20.1% to $1.63.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) dipped 18% to $1.14.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) declined 16.4% to $1,081.53 after the company reported worse-than-expected financial results for the first quarter.</li>
<li>Safe &amp; Green Holdings Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 16% to $0.1185 after declining 4% on Monday.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) declined 15.8% to $108.96 after the company reported worse-than-expected first quarter adjusted EPS results.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) fell 15% to $21.59 after the company reported worse-than-expected first-quarter sales results.</li>
<li>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) declined 13.2% to $77.22 following a first-quarter earnings miss.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares declined 13.1% to $10.34 after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 12.5% to $0.6393. Complete Solaria shares jumped 92% on Monday after the company named T.J. Rodgers as CEO.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) fell 11% to $5.18 after the company reported worse-than-expected quarterly sales results.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) declined 9.3% to $7.39 on reports NBCUniversal is preparing an offer that could take NBA rights from TNT.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) fell 7.6% to $168.36. F5 reported upbeat earnings for its second quarter, but issued weak forecast for the third quarter.</li>
<li>Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) declined 7.5% to $58.80 following quarterly results.</li>
<li>The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) fell 7.4% to $14.82 following quarterly earnings.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares declined 7.3% to $37.13. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares declined 7.3% to $56.10 following first-quarter results.</li>
</ul>
Now Read This: <a href="http://Domino's Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

Intraday Update

Movers

ADXN

AGBA

AKLI

ARCB

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLND

CETX

CHGG

COUR

CSLR

CYCC

DARE

EGOX

ELYM

ETWO

FFIV

GEHC

HEES

HLIT

LICN

MIND

MRIN

MSTR

MULN

NIVF

NRXP

RMBS

SGBX

SWVL

TREE

UAVS

VNCE

YUMC

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Braemar Hotels & Resorts (BHR – Research Report), AvalonBay (AVB...

Analysts Conflicted on These Real Estate Names: Braemar Hotels & Resorts (BHR), AvalonBay (AVB) and Macerich (MAC)

Compass Point analyst Floris van Dijkum maintained a Buy rating on Macerich (MAC – Research Report) today and set a price target of $18.00. The com...

Compass Point Remains a Buy on Macerich (MAC)

Macerich: Solid Progress, But Leverage Remains A Concern

Macerich: Probability Of Better Dividends Is Weak

Warning: MAC is at high risk of performing badly

Baron Real Estate Income Fund Q2 2024 Shareholder Letter

What I Wish I Knew Before Buying REITs

In a report released today, Alexander Goldfarb from Piper Sandler maintained a Sell rating on Macerich (MAC – Research Report), with a price target...

Piper Sandler Remains a Sell on Macerich (MAC)

Guggenheim Risk Managed Real Estate Fund Q2 2024 Commentary

SA Chart: Which sector will benefit the most from interest rate cuts?

BCAP

BROE

CLPR

CMCT

EQIX

ESRT

INVH

JBGS

NXRT

PECO

PGRE

PLDGP

RDFN

REXR

TMHC

VICI

WELL

XLRE

Press Releases

Otto Tech Systems Adds 3 New Members to Its Board of Directors

General

Macerich Launches Path-Forward Plan

Macerich To Present at Nareit's REITweek 2024 Investor Conference

Pillar Income Asset Management Announces Appointment of Erik Johnson as President and Chief Executive Officer

Comments

Macerich

Vendite allo scoperto

Macerich (NYSE:MAC) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO